Phase II Open Label, Study of IMMU-132 in Metastatic Urothelial Cancer After Failure of Platinum-Based Regimen or Anti-PD-1/ PD-L1 Based Immunotherapy
- Darcourt, Jorge (PI)
- Abdelrahim, Maen (Key Personnel)
- Bernicker, Eric H. (Key Personnel)
- Chang, Jenny C. (Key Personnel)
- Heyne, Kirk (Key Personnel)
- Niravath, Polly A. (Key Personnel)
- Singh, Monisha (Key Personnel)
Project: Clinical Trial